BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28951561)

  • 41. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
    Jin L; Hope KJ; Zhai Q; Smadja-Joffe F; Dick JE
    Nat Med; 2006 Oct; 12(10):1167-74. PubMed ID: 16998484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.
    Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C
    Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cytosolic Ezh1 isoform modulates a PRC2-Ezh1 epigenetic adaptive response in postmitotic cells.
    Bodega B; Marasca F; Ranzani V; Cherubini A; Della Valle F; Neguembor MV; Wassef M; Zippo A; Lanzuolo C; Pagani M; Orlando V
    Nat Struct Mol Biol; 2017 May; 24(5):444-452. PubMed ID: 28346433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular and Molecular State of Myeloid Leukemia Stem Cells.
    Xie X; Feng M; Wang Q; Wang J; Yin R; Li Y; Zhang H
    Adv Exp Med Biol; 2019; 1143():41-57. PubMed ID: 31338814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding.
    Peng D; Wang H; Li L; Ma X; Chen Y; Zhou H; Luo Y; Xiao Y; Liu L
    Leukemia; 2018 May; 32(5):1180-1188. PubMed ID: 29479064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental control of polycomb subunit composition by GATA factors mediates a switch to non-canonical functions.
    Xu J; Shao Z; Li D; Xie H; Kim W; Huang J; Taylor JE; Pinello L; Glass K; Jaffe JD; Yuan GC; Orkin SH
    Mol Cell; 2015 Jan; 57(2):304-316. PubMed ID: 25578878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
    Gluexam T; Grandits AM; Schlerka A; Nguyen CH; Etzler J; Finkes T; Fuchs M; Scheid C; Heller G; Hackl H; Harrer N; Sill H; Koller E; Stoiber D; Sommergruber W; Wieser R
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1.
    Ito J; Yamagata K; Shinohara H; Shima Y; Katsumoto T; Aikawa Y; Kitabayashi I
    Int J Hematol; 2023 Jan; 117(1):78-89. PubMed ID: 36280659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
    Gao L; Yu S; Zhang X
    Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression.
    Zhang Y; Peng L; Hu T; Wan Y; Ren Y; Zhang J; Wang X; Zhou Y; Yuan W; Wang Q; Cheng T; Zhu X
    Exp Hematol; 2015 Apr; 43(4):309-18.e2. PubMed ID: 25534202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells.
    Liu Y; Wei Y; Wang X; Ma L; Li X; Sun Y; Wu Y; Zhang L; Wang J; Li M; Zhang K; Wei M; Yang G; Yang C
    Eur J Med Chem; 2023 Mar; 249():115140. PubMed ID: 36736154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.
    Qi J; Singh S; Hua WK; Cai Q; Chao SW; Li L; Liu H; Ho Y; McDonald T; Lin A; Marcucci G; Bhatia R; Huang WJ; Chang CI; Kuo YH
    Cell Stem Cell; 2015 Nov; 17(5):597-610. PubMed ID: 26387755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biology and relevance of human acute myeloid leukemia stem cells.
    Thomas D; Majeti R
    Blood; 2017 Mar; 129(12):1577-1585. PubMed ID: 28159741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Autophagy; 2017 Apr; 13(4):761-762. PubMed ID: 28118076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia.
    Trost M; Sauvageau M; Hérault O; Deleris P; Pomiès C; Chagraoui J; Mayotte N; Meloche S; Sauvageau G; Thibault P
    Blood; 2012 Aug; 120(8):e17-27. PubMed ID: 22802335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status.
    Poohadsuan J; O'Doherty GA; Owattanapanich W; Kungwankiattichai S; Rojanasakul Y; Issaragrisil S; Luanpitpong S
    Cell Commun Signal; 2023 Oct; 21(1):283. PubMed ID: 37828578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.
    Herbrich S; Baran N; Cai T; Weng C; Aitken MJL; Post SM; Henderson J; Shi C; Richard-Carpentier G; Sauvageau G; Baggerly K; Al-Atrash G; Davis RE; Daver N; Zha D; Konopleva M
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.